{"id":"NCT02831998","sponsor":"Zurex Pharma, Inc.","briefTitle":"In-vivo Efficacy of Patient Preoperative Prep","officialTitle":"Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZP","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-07-27","primaryCompletion":"2017-04-09","completion":"2017-04-09","firstPosted":"2016-07-13","resultsPosted":"2021-07-19","lastUpdate":"2023-02-08"},"enrollment":440,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Surgical Skin Preparation"],"interventions":[{"type":"DRUG","name":"ZuraPrep","otherNames":["Isopropyl alcohol 70%","ZP"]},{"type":"DRUG","name":"ChloraPrep","otherNames":["CHG 2%/IPA 70%","Chlorhexidine gluconate 2% / Isopropyl alcohol 70%"]},{"type":"DRUG","name":"ZP Vehicle","otherNames":["ZP without IPA"]}],"arms":[{"label":"ZP (70% IPA)","type":"EXPERIMENTAL"},{"label":"ChloraPrep","type":"ACTIVE_COMPARATOR"},{"label":"ZP Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.","primaryOutcome":{"measure":"Bacterial Reduction","timeFrame":"10 minutes post product application","effectByArm":[{"arm":"Mean Log Reduction - ZP (70% IPA) - Groin","deltaMin":4.83,"sd":0.1},{"arm":"Mean Log Reduction - ChloraPrep - Groin","deltaMin":4.78,"sd":0.1},{"arm":"Mean Log Reduction - ZP Vehicle - Groin","deltaMin":2.23,"sd":0.2}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["32131912"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":400},"commonTop":[]}}